Postmenopausal women with osteoporosis are nearly 50 per cent more likely to die prematurely, according to new research. The fragile-bone condition has long been known to raise the chances of potentially life-threatening fractures, but the study has now found it also puts sufferers at greater risk from other serious health issues, such as heart disease and dementia.
Nearly 3.5 million people in the UK live with osteoporosis, a condition characterised by weakened bones that predominantly affects postmenopausal women. As oestrogen levels decline, bones break down faster and rebuild more slowly, causing bone density to drop, particularly in the hip area.
The latest study, published in the medical journal Menopause last week, analysed the bone mineral density of nearly 3,000 postmenopausal women. It found that higher bone mineral density was linked to a longer life and also reduced the risk of serious health conditions.
The study authors concluded that bone mineral density should be used as a marker of overall health. Experts say early screening for the disease is vital.
The Mail on Sunday, together with the Royal Osteoporosis Society, has been campaigning for the full rollout of fracture liaison services (FLS) — screening clinics that aim to detect osteoporosis before a debilitating fracture occurs. The Royal Osteoporosis Society charity estimates that 2,500 people die every year from the effects of preventable hip fractures.
The Government has committed to full coverage of FLS by 2030, but critics say that without immediate action this target will not be met. An analysis by the charity suggests that the failure to roll out services has resulted in 17,000 preventable fractures.
Dr Monica Christmas, associate medical director at The Menopause Society, said: 'Early screening and preventive measures, including a calcium-rich diet preferably from food sources, regular weight-bearing exercise and hormone therapy when appropriate, can significantly improve bone health and reduce risks not only of fractures but also cardiovascular disease, certain cancers, and dementia. It is time we bring this conversation to the forefront.'
